HLI vs CRCL
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
HLI · Houlihan Lokey$132.07 ▼ 2.68%
CRCL · Circle$47.51 ▼ 8.42%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- HLI -22.1%
- CRCL -34.7%
Head to head
| Metric | HLI | CRCL |
|---|---|---|
| Price | $132.07 | $47.51 |
| Change today | ▼ 2.68% | ▼ 8.42% |
| Market cap | $9.17B | $12.19B |
| Return, 3 months | +3.0% | -45.8% |
| Return, year to date | -23.1% | -40.1% |
| Return, 1 year | -22.6% | -33.4% |
| P/E (TTM) | 22.2 | 26.2 |
| P/B | 4.0 | 3.2 |
| P/E percentile vs own 5y | 39th | 67th |
| Dividend yield | 1.97% | – |
| Revenue growth (YoY, latest qtr) | +4.8% | +16.9% |
| Net profit growth (YoY) | -0.9% | +5.4% |
| Gross margin | 38.5% | 26.6% |
| Operating margin | 22.8% | 11.3% |
| Net margin | 15.8% | 15.3% |
| Return on equity | 17.7% | 13.4% |
| Analyst target vs. price | +21.5% | +121.0% |
| Analyst buy share | 75% | 61% |
| RSI (14) | 40 | 21 |
| 30-day volatility | 39.7% | 72.2% |
| Max drawdown, 1 year | -35.2% | -64.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CRCL is the largest of the group by market value.
- HLI has returned the most over the past year.
- HLI carries the lowest trailing P/E.
- CRCL is growing revenue fastest.
- HLI keeps the most profit per dollar of sales.
- HLI has been the calmest stock over the last 30 days.